Final development and validation of the BOMET-QoL questionnaire for assessing quality of life in patients with malignant bone disease due to neoplasia

Journal of Medical Economics

Volumn 10, Issue 1, 2007, Pages 27-39

  Sureda, A ^a   Isla, D ^b   Cozar J M ^c   Ruiz, M ^d   Domine, M ^e   Margeli M ^f   Adrover, E ^g   Ramos, M ^h   Pastor, M ⁱ   Martin A ^j   Llombart, A ^k   Massuti, B ^g   Munoz M ^l   Barnadas, A ^a   Fernandez J ^m   Colomer, R ⁿ   Allepuz, C ^o   Gilabert, M ^p   Badia, X ^q  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^e Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^f HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^g HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^h Hospital Oncologico de Galicia   (Spain)

ⁱ HOSPITAL UNIVERSITARIO LA FE   (Spain)

^j HOSPITAL DE CABUEÑES   (Spain)

^k INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^l HOSPITAL CLÍNIC   (Spain)

^m HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

ⁿ CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^o Hospital Miguel Servert   (Spain)

^p SA   (Spain)

^q Health Outcomes Research Europe   (Spain)

more..

Author keywords

Bone metastasis; Myeloma; Quality of life; Questionnaires

Indexed keywords

ADULT; AGED; ARTICLE; BONE CANCER; BONE DISEASE; CLINICAL PRACTICE; CORRELATION COEFFICIENT; DATA ANALYSIS; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; QUALITY OF LIFE; QUESTIONNAIRE; RASCH ANALYSIS; RELIABILITY; VALIDATION STUDY;

EID: 34147109265     PISSN: 13696998     EISSN: None     Source Type: Journal    
DOI: 10.3111/200710027039     Document Type: Article

References (43)

1. Cella D, Chang CH, Lai JS et al. Advances in quality of life measurements in oncology patients. Seminars in Oncology 2002; 29(3 Suppl 8): 60-68.
2. Badia X, Muriel C, Gracia A et al. [Validation of the Spanish version of the Brief Pain Inventory in patients with oncological pain.] Medicina Clínica 2003; 120: 52-59 [in Spanish].
3. Tusquets I. Clínica, diagnóstico y evolución de las metástasis óseas: su importancia en la calidad de vida del paciente. Revisiones en Cáncer (Madrid) 2001; 15(Suppl. 1): 15-19.
4. Martinez MJ, Roque M, Alonso-Coello P et al. Calcitonin for metastatic bone pain. Cochrane Database of Systematic Reviews 2003; 3: CD003223
5. Lipton A. Bone metastases in breast cancer. Current Treatment Options in Oncology 2003; 4: 151-158.
6. Reddi AH, Roodman D, Freeman C et al. Mechanisms of tumor metastasis to the bone: challenges and opportunities. Journal of Bone and Mineral Research 2003; 18: 190-194.
7. Radford M, Gibbons CL. Management of skeletal metastases. Hospital Medicine 2002; 63: 722-725.
8. Bunting RW, Shea B. Bone metastasis and rehabilitation. Cancer 2001; 92(4 Suppl.): 1020-1028.
9. Guo Y, Young B, Palmer JL et al. Prognostic factors for survival in metastatic spinal cord compression: a retrospective study in a rehabilitation setting. American Journal of Physical Medicine & Rehabilitation 2003; 82: 665-668.
10. Van Poznak CH. The use of bisphosphonates in patients with breast cancer. Cancer Control 2002; 9: 480-489.
11. Pickering LM, Mansi JL. The role of bisphosphonates in breast cancer management: review article. Current Medical Research and Opinion 2002; 18: 284-295.
12. Hortobagyi GN. Moving into the future: treatment of bone metastases and beyond. Cancer Treatment Reviews 2005; 31(Suppl. 3): 9-18.
13. Djulbegovic B, Wheatley K, Ross J et al. Bisphosphonates in multiple myeloma. Cochrane Database of Systematic Reviews 2002;3:CD003188.
14. Osoba D. Health-related quality-of-life assessment in clinical trials of supportive care in oncology. Supportive Care in Cancer 2000;8:84-88.
15. Porter GA, Skibber JM. Outcomes research in surgical oncology. Annals of Surgical Oncology 2000; 7: 367-375.
16. Roila F, Cortesi E. Quality of life as a primary end point in oncology. Annals of Oncology 2001; 12(Suppl. 3): S3-S6.
17. Schwartz CE, Sprangers MA. An introduction to quality of life assessment in oncology: the value of measuring patient-reported outcomes. Amercian Journal of Managed Care 2002; 18 (18 Suppl.): S550-S559.
18. Ganz PA, Schag CA, Lee JJ et al. The CARES: a generic measure of health-related quality of life for patients with cancer. Quality of Life Research 1992; 1: 19-29.
19. Aaronson NK, Ahmedzai S, Bergman B et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute 1993; 85: 365-376.
20. Cella DF, Tulsky DS, Gray G et al. The Functional Assessment of Cancer Therapy (FACT) scale: development and validation of the general measure. Journal of Clinical Oncology 1993; 11: 570-579.
21. Watson M, Law M, Maguire GP. Further development of a quality of life measure for cancer patients: the Rotterdam Symptom Checklist (revised). Psychooncology 1992; 1: 35-44.
22. Adrover E, Allepuz J, Sureda A. Development of a questionnaire to measure health-related quality of life (HRQoL) in patients with bone metastases (BOMET-QoL). Journal of Outcomes Research 2005; 9: 15-27.
23. Badia X, Carné X. [Evaluation of quality of life in clinical trials.] Medicina Clinica 1998; 110: 550-556 [in Spanish].
24. Nunnally JC, Bernstein IH. Psychometric Theory. New York, NY: McGraw-Hill, 1994.
25. Oken MM, Creech RH, Tormey DC et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. American Journal of Clinical Oncology 1982; 5: 649-655.
26. Cleeland CS. Research in cancer pain: what we know and what we need to know. Cancer 1991; 67: 823-827.
27. Croker L, Algina J. Introdution to Classical and Modern Theory. Fort Worth, TX: Holt, Rinehart and Winston, 1986.
28. Bond TG, Fox CM. Applying the Rasch model. In: Fundamental Measurement in the Human Sciencies. Mahwah, NJ: Lawrence Erlbaum Associates Publishers, 2001: 7-34.
29. Fitzpatrick R, Fletcher A, Gore S et al. Quality of life measures in health care. I: Aplications and issues in assessment. British Medical Journal 1992; 305: 1074-1077.
30. Bland JM, Altman DG. Cronbach's alpha. British Medical Journal 1997; 314: 572.
31. Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. Controlled Clinical Trials 1991; 12 (4 Suppl.): 142S-158S.
32. Yount S, Cella D, Banik D et al. Brief assessment of priority symptoms in hormone refractory prostate cancer: the FACT Advanced Prostate Symptom Index (FAPSI). Health and Quality of Life Outcomes 2003; 1: 69.
33. Bezjak A, Taylor KM, Ng P et al. Quality of life information and clinical practice: the oncologist's perpective. Cancer Prevention & Control 1998; 2: 230-235.
34. Badia X, Díez-Pérez A, Lahoz R et al. The ECOS-16 questionnaire for the evaluation of health related quality of life in postmenopausal women with osteoporosis. Health and Quality of Life Outcomes 2004; 2: 41.
35. Prieto L, Lamarca R, Santed R. Classical test theory versus Rasch analysis for health-related quality of life questionnaire reduction. Quality of Life Research 1999; 8: 652.
36. Gómez Batiste X, Madrid F, Moreno F et al. Breakthrough cancer pain: prevalence and characteristics in patients in Catalonia, Spain. Journal of Pain and Symptom Management 2002: 24: 45-52.
37. Portenoy RK, Payne D, Jacobsen P. Breakthrough pain: characteristics and impact in patients with cancer pain. Pain 1999; 81: 129-134.
38. Earlam S, Glover C, Fordy C et al. Relation between tumor size, quality of life and survival in patients with colorectal liver metastases. Journal of Clinical Oncology 1996; 14: 171-175.
39. Maisey NR, Norman A, Watson M et al. Baseline quality of life predicts survival in patients with advanced colorectal cancer. European Journal of Cancer 2002; 38: 1351-1357.
40. Mystakidou K, Tsilika E, Kouloulias V et al. The 'Paliative Care Quality of Life Instrument (PQLI)' in terminal cancer patients. Health and Quality of Life Outcomes 2004; 2: 8
41. Osse BH, Vernooij MJ, Schade E et al. Towards a new clinical tool for needs assessment in the palliative care of cancer patients: the PNPC instrument. Journal of Pain and Symptom Management 2004; 28: 329-341.
42. Conroy T, Bleiberg H, Glimelius B. Quality of life in patientes with advanced colorectal cancer: what has been learnt? European Journal of Cancer 2003; 39: 287-294.
43. Lundh Hagelin C, Seiger A, Furst CJ. Quality of life in terminal care - with special reference to age, gender and marital status. Supportive Care in Cancer 2006; 14: 320-328.